Literature DB >> 16302960

Structures for amyloid fibrils.

O Sumner Makin1, Louise C Serpell.   

Abstract

Alzheimer's disease and Creutzfeldt-Jakob disease are the best-known examples of a group of diseases known as the amyloidoses. They are characterized by the extracellular deposition of toxic, insoluble amyloid fibrils. Knowledge of the structure of these fibrils is essential for understanding the process of pathology of the amyloidoses and for the rational design of drugs to inhibit or reverse amyloid formation. Structural models have been built using information from a wide variety of techniques, including X-ray diffraction, electron microscopy, solid state NMR and EPR. Recent advances have been made in understanding the architecture of the amyloid fibril. Here, we describe and compare postulated structural models for the mature amyloid fibril and discuss how the ordered structure of amyloid contributes to its stability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302960     DOI: 10.1111/j.1742-4658.2005.05025.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  98 in total

1.  Inflammation protein SAA2.2 spontaneously forms marginally stable amyloid fibrils at physiological temperature.

Authors:  Zhuqiu Ye; Diane Bayron Poueymiroy; J Javier Aguilera; Saipraveen Srinivasan; Yun Wang; Louise C Serpell; Wilfredo Colón
Journal:  Biochemistry       Date:  2011-10-05       Impact factor: 3.162

2.  Characterizing the assembly of the Sup35 yeast prion fragment, GNNQQNY: structural changes accompany a fiber-to-crystal switch.

Authors:  Karen E Marshall; Matthew R Hicks; Thomas L Williams; Søren Vrønning Hoffmann; Alison Rodger; Timothy R Dafforn; Louise C Serpell
Journal:  Biophys J       Date:  2010-01-20       Impact factor: 4.033

3.  Can molecular dynamics simulations assist in design of specific inhibitors and imaging agents of amyloid aggregation? Structure, stability and free energy predictions for amyloid oligomers of VQIVYK, MVGGVV and LYQLEN.

Authors:  Workalemahu Mikre Berhanu; Artëm E Masunov
Journal:  J Mol Model       Date:  2010-12-21       Impact factor: 1.810

4.  Regenerable and simultaneous surface plasmon resonance detection of aβ(1-40) and aβ(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody.

Authors:  Ning Xia; Lin Liu; Michael G Harrington; Jianxiu Wang; Feimeng Zhou
Journal:  Anal Chem       Date:  2010-11-12       Impact factor: 6.986

5.  Crystal Structures of IAPP Amyloidogenic Segments Reveal a Novel Packing Motif of Out-of-Register Beta Sheets.

Authors:  Angela B Soriaga; Smriti Sangwan; Ramsay Macdonald; Michael R Sawaya; David Eisenberg
Journal:  J Phys Chem B       Date:  2016-01-11       Impact factor: 2.991

Review 6.  Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.

Authors:  Durga Dharmadana; Nicholas P Reynolds; Charlotte E Conn; Céline Valéry
Journal:  Interface Focus       Date:  2017-06-16       Impact factor: 3.906

7.  Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities.

Authors:  Jie Zheng; Hyunbum Jang; Buyong Ma; Chung-Jun Tsai; Ruth Nussinov
Journal:  Biophys J       Date:  2007-08-03       Impact factor: 4.033

Review 8.  Nanoimaging for protein misfolding and related diseases.

Authors:  Yuri L Lyubchenko; Simon Sherman; Luda S Shlyakhtenko; Vladimir N Uversky
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

9.  Molecular dynamics analyses of cross-beta-spine steric zipper models: beta-sheet twisting and aggregation.

Authors:  Luciana Esposito; Carlo Pedone; Luigi Vitagliano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

Review 10.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.